Study S001923

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction: a Randomized and Double-blind Clinical Trial

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT06557811
Acronym: SemaFatCard
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 88
Start: 2024-09-01
Primary completion: 2024-09-01
Lead sponsor: University of Sao Paulo General Hospital
Conditions: Diabetic Patients; Acute Myocardial Infarction
Interventions: DRUG:Semaglutide
Results posted: FALSE

Registered primary outcomes

Measurement of pericardial adipose tissue at 180 days [180 days]
Measurement of the fat attenuation index at 180 days [180 days]
Measurement of the perivascular adipose tissue attenuation index at 180 days [180 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.